Antiviral activity of small interfering RNAs: Specificity testing using heterologous virus reveals interferon-related effects overlooked by conventional mismatch controls  by Schyth, Brian Dall et al.
6) 134–141
www.elsevier.com/locate/yviroVirology 349 (200Antiviral activity of small interfering RNAs: Specificity testing using
heterologous virus reveals interferon-related effects overlooked by
conventional mismatch controls
Brian Dall Schyth a,b,⁎, Niels Lorenzen a, Finn Skou Pedersen b
a Danish Institute for Food and Veterinary Research, Hangøvej 2, 8200 Århus N, Denmark
b Department of Molecular Biology, University of Aarhus, C.F. Møllers Allé, 8000 Århus C, Denmark
Received 15 October 2005; returned to author for revision 23 November 2005; accepted 4 January 2006
Available online 15 February 2006Abstract
RNA interference by small interfering RNAs (siRNAs) is considered to be a highly specific method for knockdown of gene expression in
eukaryotic cells via degradation of target mRNA. Mutated siRNA molecules with 1–4 mismatching nucleotides compared to the target mRNA are
regularly used as specificity controls. Using siRNAs for inhibition of a fish-pathogenic rhabdovirus, we report that inclusion of a heterologous
virus, as target control is essential for verification of the specificity of siRNA-induced interference with virus multiplication. Transfection with
three different siRNAs specific to the viral glycoprotein gene of the target-virus efficiently inhibited viral multiplication in infected cell cultures,
while two of three corresponding mismatched siRNAs did not have this effect. This suggested specific interference, but similar results were
obtained when the same siRNAs were tested against a heterologous virus. Further analyses revealed that the siRNAs induced a non-target-specific
anti-viral effect correlating with upregulation of the interferon induced Mx gene.
© 2006 Elsevier Inc. All rights reserved.Keywords: RNA interference; Target control; IFN; Mx; RhabdovirusIntroduction
RNA interference, or RNAi, is a mechanism in the
eukaryotic cell that confers sequence-specific degradation of
single-stranded RNA (ssRNA) targets, mediated by double-
stranded RNAmolecules (dsRNA) with sequence identity to the
target RNA. The mechanism is mediated by an RNase III family
enzyme called Dicer that cuts the dsRNA into 21–23 bp small
interfering RNAs or siRNAs (Zamore et al., 2000) and a
multicomponent complex called the RNA-induced silencing
complex, or RISC, which uses the individual strands of the
siRNA as a guide to target and degrade ssRNA (Zamore et al.,
2000; Schwarz et al., 2004). The RNAi concept was first
discovered in plants and nematode worms (Fire et al., 1998) but
has later been demonstrated in cells of mammals (Elbashir et al.,
2001) and other vertebrates (Caplen et al., 2001) like fish (Dodd⁎ Corresponding author. Danish Institute for Food and Veterinary Research,
Hangøvej 2, 8200 Århus N, Denmark. Fax: +45 72346901.
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doi:10.1016/j.virol.2006.01.009et al., 2004; Boonanuntanasarn et al., 2003; Li et al., 2000;
Wargelius et al., 1999; Nasevicius and Ekker, 2000; Xie et al.,
2005), making RNAi a potential therapeutic tool in human and
veterinary medicine. The finding that the RNAi system
effectively degraded cognate mRNAs, when induced only by
the 21–23 bp long siRNAs, was a major breakthrough, as the
smaller siRNAs compared to the longer dsRNAs apparently did
not activate the cellular interferon response (Elbashir et al.,
2001), which is known to induce a general inhibition of the
cellular translational machinery as well as non-specific antiviral
responses in the cell (Samuel, 2001). This should allow siRNA-
mediated RNAi to be used for specific targeting of intracellular
pathogens like viruses, and indeed in the field of virology, the
technique has been used extensively as recently reviewed (Tan
and Yin, 2004; Leonard and Schaffer, in press). The in vitro
transcription method of generating siRNAs is an easy and
inexpensive way of producing small interfering RNAs with
high potency (Sohail et al., 2003; Donzé and Picard, 2002). One
major drawback of the method is that the T7 phage polymerase
transcribed siRNAs have in some cases been shown able to
Fig. 1. Optimised transfection of siRNAs into EPC cells using fluorochrome-
labeled non-specific siRNAs. (A) Fluorescence microscopy using FITC filter
on mock-transfected cells treated only with the transfection agent (Mirus
Trans-It TKO). (B) Cells transfected with 40 nM of fluorescently labeled
siRNA 48 h post-transfection. (C) Light microscopy of cell layer mock-
transfected using only the transfection agent. (D) Cell layer transfected with
100 nM siRNA shows no notable cytotoxicity.
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al., 2003; Kim et al., 2004), an effect that has also been seen for
some chemically synthesized siRNAs (Jackson et al., 2003; Qiu
et al., 2005; Sledz et al., 2003). Due to its antiviral nature, a
cellular interferon response should be given special concern in
studies of RNAi targeting viruses, where reduced replication in
siRNA-transfected cells is often taken as indicative of
successful specific interference (Kapadia et al., 2003; Bhuyan
et al., 2004; Xie et al., 2005). Controls for target-specificity in
antiviral RNAi studies have typically been, e.g., non-specific
control siRNAs made against target-irrelevant genes like the
housekeeping gene glyceraldehyde-3-phosphate dehydrogenase
(GADPH) (Kapadia et al., 2003), or reporter genes like the
green fluorescent protein (GFP), but these – in terms of
sequence – very different siRNAs, may not fully address the
matter of siRNA specificity. Alternatively, mismatched or
scrambled siRNA controls, which have the target specific
sequence except for 1–4 mismatches, have been applied
(Kapadia et al., 2003; Xie et al., 2005). In the work presented
here, we used a heterologous viral target control in order to
change the target instead of changing the siRNA. By using this
approach, we observed non-specific siRNA-induced antiviral
responses that our mismatched controls were not always able to
unveil. The work was performed with fish rhabdoviruses in fish
cell cultures. Our target was the rainbow trout pathogenic virus
viral hemorrhagic septicemia virus (VHSV). The viral genome
is 11 kb long, containing six open reading frames encoding the
nucleoprotein N, phosphoprotein P, matrix protein M, glyco-
protein G, non-structural protein NV and the polymerase L
arranged in that order from 3′ to 5′ end (Schutze et al., 1999).
We designed our siRNAs to target the mRNA transcript
encoding the viral glycoprotein G.
Results
Transfection of siRNAs into fish cells
Transfection of siRNAs into the carp cell line epithelioma
papulosum cyprinid or EPC (Fijan et al., 1983) was optimized
and verified by using fluorochrome-labeled chemically synthe-
sized non-specific siRNAs (Qiagen). The ratio of the transfec-
tion agent to siRNA was optimized to give maximal uptake
without evoking notable cytotoxicity in the cell layers. The
siRNAs seemed to be distributed evenly in the cytoplasm of
highly transfected cells but appeared as dots in less transfected
cells 24 and 48 h post-transfection (Fig. 1).
Production of siRNAs
VHSV glycoprotein specific siRNAs and their corresponding
mismatched control siRNAs (Table 1) were made by in vitro
transcription. In 12% PAGE, these siRNA preparations all
showed one product migrating a slightly shorter distance than
the 25 bp DNA marker except for si776 and si776M which in
addition contained a smaller more abundant band (Fig. 2). The
smaller bandsmigrated like two chemically synthesized versions
of the same siRNAs leading us to believe that these bandscorresponded to the specific siRNA sequences.We noted a slight
difference in mobility between si776 and its mismatched control
for both the in vitro transcribed and the chemically synthesized
siRNAs.
Knockdown of viral replication by in vitro transcribed siRNAs
When cells were transfected with 80 nM si88, si776 or si932
prior to challenge with VHSV, all of these siRNAs were able to
inhibit replication of VHSV significantly compared to the mock-
transfected control (Figs. 3A, B and C; right side graphs).
Accordingly, the cells were protected from cytopathogenic effect
(CPE), which is normally seen as rounding, swelling and
loosening of cells in which rhabdoviruses replicate (Fig. 3, left
panel of B and C). At least for si776 and si932, the inhibition was
concentration dependent, as there was neither significant
reduction in viral titer nor a protection of the EPC cells against
the virus using only 20 nM of the siRNAs. As was the case for
the chemically synthesized fluorescent siRNAs, no toxic effects
on the transfected cells was observed using the in vitro
transcribed siRNAs.
Mismatched siRNA controls
To check for siRNA sequence specificity, the mismatched
controls si88M, si776M and si932M were used. These were
designed to have four internal nucleotides, which were not
complementary to the respective target sites in the VHSV-G
gene (Table 1). Si88M and si776M did not protect the cells
against VHSV neither at 20 nM nor at 80 nM (Figs. 3A and
B), whereas 80 nM si932M lowered the viral titer enough to
protect the cell layers against CPE 96 h post-virus inoculation
(Fig. 3C). Thus, it would appear that si88 and si776 gave a
sequence specific knockdown of VHSV, as only 4 mismatches
Table 1
siRNAs and mismatched control siRNAs used in this study
siRNAa Target sequence b Mismatches
compared to: c
VHSV-G SVCV-G
si88 5′-AACAUCUCGACGUACCAUGCA-3′ 0 12
si88M 5′-AACAUCCCGACAUGCCAUACA-3′ 4 10
si776 5′-AAUGGAUCAAGACUGACCUGG-3′ 0 8
si776M 5′-AAUGGACCAAGGCCGACCCGG-3′ 4 9
si932 5′-AAAGAACCGAGUGCCUAGAUG-3′ 0 9
si932M 5′-AAAGAAUCGAGCGUCUAGGUG-3′ 4 10
a 88, 776 and 932 respectively denotes the starting nt of the target area relative
to the start codon on the VHSV-G transcript. M denotes a control siRNAwith 4
mismatches compared to the VHSV-G target sequence.
b Target sequences in the VHSV glycoprotein mRNA. For the control
siRNAs, the mismatched nucleotides, compared to the VHSV-G target, are
underlined.
c Mismatches between the specific target of the siRNA antisense strand and the
most optimal target sequence found in the mRNA of VHSV-G (X66134) or the
control virus SVCV-G (AJ318079).
Fig. 2. Size and purity of the in vitro transcribed siRNA preparations. Si88,
si776, si932 and the mismatched controls si88M, si776M and si932M were
examined by 12% PAGE. The DNA marker used is composed of products
separated by 25 bp in size. 12% PAGE of chemically synthesized si776 and
si776M (see Materials and methods) have also been included.
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In the case of si932, the silencing effect appeared to be less
target specific, since si932M also interfered with replication of
VHSV.
Heterologous viral target control
In order to further examine the specificity aspect of the
observed siRNA effect, we inoculated siRNA-transfected cells
with a different fish rhabdovirus spring viraemia of carp virus
(SVCV) instead of VHSV. As shown in Figs. 4A, B and C, the
siRNAs protected the cells against SVCV in a similar pattern as
observed for VHSV, although for SVCV also si776M seemed
able to reduce titers slightly, but significantly, without
protecting the cell layers against CPE 96 h post-virus
inoculation. Si88 was also shown to protect the cells against a
third fish rhabdovirus namely infectious hematopoietic necrosis
virus (IHNV) belonging to the novirhabdoviridae subfamily
like VHSV (Van Regenmortel et al., 2000) (data not shown).
The 4-base mutated si88M did not induce protection against any
of the viruses. It would appear that si88 and si776 worked in a
highly specific manner, had they not been tested using a non-
specific viral control.
IFN activity of the in vitro transcribed siRNAs
Based on earlier work, the multiplication of the fish
rhabdoviruses was presumed to be sensitive to IFN-induced
defence mechanisms (Masycheva et al., 1995; Rogel-Gaillard
et al., 1993), and this was confirmed in the applied setup
where pretreatment of the EPC cells with long synthetic
dsRNA molecules (poly[I]-poly[C]) protected the cells against
CPE and reduced viral titers following inoculation with VHSV
or SVCV (Fig. 5). To examine whether similar mechanisms
could explain the observed interference induced by our
siRNAs, it was tested whether transfection of EPC cells with
the siRNAs and their mismatched controls had any effect onthe expression of the antiviral IFN-induced Mx1 protein.
Protection of cell layers transfected with si88, si776, si932 and
si932M was most likely due to an interferon type 1 response,
as EPC cells transfected with these showed the highest
expression of the IFN induced carp Mx1 (Figs. 6A, B and C).
Si88 gave high protection of cell layers at both 20 and 80 nM
(Figs. 3A and 4A), and accordingly, this siRNA induced a
very high level of Mx expression at 80 nM (∼427-fold). At 20
nM si776, si932 and si932M gave only a small or no
upregulation of Mx compared to the background level, but a
rise to ∼27-, ∼63- and ∼12-fold respectively was seen in cells
transfected with 80 nM of these siRNAs, presumably
explaining why high protection of the cell layers was only
seen when using the high concentration of these siRNA (Figs.
3 and 4). Even when using 80 nM of si776M, Mx was only
∼3-fold upregulated compared to the mock-treated cells. This
finding corresponded well with si776M giving no protection
against VHSV and only a weak protection against SVCV
(Figs. 3B and 4B). Chemically synthesized si776 and si776M
did not protect cell layers, when tested in the viral assay, at
least not for long enough to inhibit CPE nor to reduce viral
titer of either VHSV or SVCV after 3 days of incubation (Fig.
7A). Also, they did not upregulate Mx expression above
background level in the cells (Fig. 7B). This strongly
supported the assumption that the antiviral effect observed
for the in vitro transcribed si776 was not due to target-specific
interference.
Discussion
In vitro transcribed siRNAs have recently been accused of
being potential inducers of the antiviral IFN type I response
in mammalian cells (Sledz et al., 2003; Kim et al., 2004), and
this study shows that the same problem is of relevance, when
describing a specific virus knockdown in other vertebrate
cells like fish cells. The difference in antiviral activity of our
siRNAs clearly correlated with their different abilities to
evoke an IFN-related response in the cells. Induction of IFN
by some in vitro transcribed siRNAs thus likely explains our
observations although we cannot exclude other parameters.
Fig. 3. VHSVinfection trials on siRNA-transfected EPC cells. EPC cells in 24-well plateswere transfectedwith 0 (mock), 20 and 80 nMof siRNA in triplicate wells. The
cells were inoculated with 102 TCID50/ml VHSV 24 h post-transfection. VHSV titers in cell culture supernatants were determined 72 h post-inoculation (right panel). At
96 h post-inoculation, cell layers were fixedwith 80% acetone and stainedwith crystal violet to show the level of cell layer protection by the siRNAs and themismatched
control siRNAs (left panel). A violet-stained well indicates an intact or nearly intact cell layer. The experiments included si88 and the mismatched control si88M (A),
siRNA si776 and si776M (B) and si932 and si932M (C). *Denotes a significant difference in titer compared to the mock-transfected control (0 nM). Tests were done in
triplicate. Titers are given as mean ± SD.
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different in vitro transcribed siRNAs. When using mis-
matched RNA control sequences to evaluate specificity of
RNAi in viral studies such differences could be problematic.
The mismatch control approach may lead to false conclusions,
if the specific siRNA and the control siRNA differ in their
ability to induce an IFN response in a given cell line. This
difference may be related to motifs in the siRNA sequence
itself (Judge et al., 2005) or elements introduced by the in
vitro transcription procedure (Kim et al., 2004).
In the last step of the in vitro method, the siRNA products
are treated with a single-strand-specific T1 RNase to remove
the T7-polymerase-specific 5′-pppGpGpGp moieties, which
have been associated with IFN production in mammalian cells
(Kim et al., 2004). This treatment may not always be equally
successful and could result in batch-to-batch differences in the
siRNAs ability to induce an IFN response. The dual-band
pattern of our in vitro transcribed siRNAs si776 and si776M
might correspond to the siRNA with and without the 5′end,
reflecting a partial removal of the 5′ overhangs by T1 RNase.
Accordingly, we observed that the lower bands in our in vitro
transcribed si776 and 776M preparations migrated like the
corresponding synthetic siRNAs (Fig. 2). Whether the lack of
antiviral effect of the synthetic si776 compared to the strongresponse induced by the in vitro transcribed si776 might be
due to the presence of an IFN-inducing motif in the upper
band of the latter requires further studies of IFN inducing
RNA motifs to be determined. In general, our observations on
antiviral activity could not be explained by size-related
differences between the siRNAs, since there was no clear
relationship between gel migration and the antiviral effects of
the molecules.
Small interfering RNAs are regularly used in viral studies
(Tan and Yin, 2004; Leonard and Schaffer, in press). In a
recent report on RNAi knockdown, in vitro transcribed
siRNAs were used to target the major capsid protein from
Iridovirus-tiger frog virus (Xie et al., 2005). It was shown
that the specific viral RNA was reduced in siRNA treated
cells, and that this reduction correlated with a reduction in
viral titer. The authors used mismatched controls with 1 and
4 mismatches respectively to check for specificity of their
siRNAs but did not look for expression of IFN induced
antiviral molecules. Kapadia et al. (2003) found that their in
vitro siRNAs induced MxA mRNA expression by b2.7-fold
in Huh-7 cells, which was below the ∼12-fold induction,
that was needed for the cells to inhibit replication of
hepatitis C (HCV). In our studies, inhibition of rhabdoviral
replication was also observed for siRNAs inducing an Mx
Fig. 4. SVCVinfection trials on siRNA-transfected EPC cells. The experiments were done as outlined in Fig. 3, except that the cells were inoculatedwith 102 TCID50/ml
SVCV. The experiments included siRNA si88 and the mismatched control si88M (A), si776 and si776M (B) and si932 and si932M (C). Like in Fig. 3, * denotes a
significant difference in titer compared to the mock-transfected control (0 nM).
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herpes simplex virus type 1 (HSV-1) tested for IFN-β
production in HaCaT cells transfected with in vitro
transcribed siRNA against the virus but concluded that the
observed 24-fold increase in IFN-β protein was not enough
to interfere with HSV-1 at detectable level (Bhuyan et al.,
2004). We measured Mx expression and used a heterologous
IFN-sensitive virus as control in our assay in order to test
for both IFN induction and functional antiviral activity at
the same time.Fig. 5. Effect of IFN stimulation on multiplication of VHSV and SVCV. EPC
cells were stimulated with 0, 0.1 and 10 μg/ml poly[I]-poly[C] to induce IFN
production. Cells were inoculated with 102 TCID50/ml virus 24 h after addition
of poly[I]-poly[C] to the medium. Viral titer values were determined 72 h post-
inoculation. Tests were done in triplicate, and titers are given as mean ± SD.It is known that both in vitro transcribed siRNAs, small
hairpin RNAs on DNAvectors, chemically synthesized siRNAs
and ssRNAs are in some cases able to induce the IFN mediated
Jak-Stat pathway and activate antiviral factors upregulated by
this pathway (Bridge et al., 2003; Kariko et al., 2004a, 2004b;
Kim et al., 2004; Judge et al., 2005). The exact mechanism or
mechanisms behind this are not yet known, but at least some
siRNAs seem to act through the toll like receptor 3 (TLR3)
(Kariko et al., 2004a; Kariko et al., 2004b), whereas ssRNAs
can be recognized by TLR7, also leading to an antiviral
response (Diebold et al., 2004; Heil et al., 2004). In general,
further dissection of the RNAi mechanism as well as other
mechanisms of small dsRNAs in the cell is needed, before the
results of RNAi experiments can be interpreted in a clear-cut
manner. As an example, it was recently described that GU-rich
motifs in siRNA sequences were able to induce interferons and
inflammatory cytokines both in vivo and in vitro (Judge et al.,
2005). As the same motifs in ssRNAs acts immunostimulatory
through TLR7 recognition (Diebold et al., 2004; Heil et al.,
2004), it was suggested that siRNAs may act as ssRNAs if
denatured in situ into their constituent oligonucleotides. In the
present study, we cannot exclude this possibility since residual
ssRNA would not have shown up in the 12% PAGE.
With the current complexity of the field, easy to use non-
biased specificity controls are important. Our viral target
specificity control revealed activation of general antiviral
Fig. 7. Testing synthetic si776 and si776M for knockdown of VHSVand SVCV
and for Mx upregulation. Tests were performed as described in Figs. 3 and 6
respectively. (A) Viral assay on EPC cells either subjected to mock transfection,
si776 or si776M transfection 24 h prior to inoculation with the respective virus.
Like in Fig. 3 titer-values were measured by titration on supernatant taken 72
h post-inoculation. (B) Carp Mx1 real-time PCR on RNA purified from EPC
cells 24 h after either mock transfection, treatment with 10 μg/ml Poly [I]-poly
[C] (positive control), si776 or si776M-transfection.
Fig. 6. Induction of the IFN pathway by siRNAs. EPC cells were transfected
with 0 (mock), 20 and 80 nM siRNA. RNAwas purified 24 h later and used in a
cDNA synthesis to generate the template for Carp Mx1 expression analysis by
real-time PCR. Mx expression values were normalized to Carp β-actin and
divided by background values from the mock-treated control. Upregulation is
noted above the bars for cells treated with 80 nM siRNA concentrations (ex.
~x27 for 80 nM si776 treated cells). Experiments included si776 and si776M
(A), si932 and si932M (B) and si88 and si88M (C). Tests were done in triplicate.
Expression data are given as mean ± SD.
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and although we cannot exactly pinpoint the underlying
mechanisms, we consider such a functional target control to be
a convenient tool for assessing whether there are other factors
than RNAi in play. Regardless of the type of siRNA used, a viral
target control represents an inexpensive and easy to apply
supplement to mismatched RNA sequence controls, when
studying the effect of a given siRNA treatment.Materials and methods
Production of siRNAs
Double-stranded small RNAs were produced with the
silencer construction kit (Ambion, UK, Cat. no. 1620)
according to the manufacturer's protocol. Target sequences
were identified in the cDNA sequence of the glycoprotein G
from VHSV isolate DK-3592B (accession no. X66134), by
scanning the sequence for 21 nt sequences with AA at the 5′
end, a GC content b50% and avoiding N4 A or Ts in a row.
The latter is the end signal for pol III promoters like T7, which
is used in the siRNA construction procedure. Of the sequences
found, three were chosen based on low homology to other
genes in fish, humans and mouse as verified by BLASTN
searches. A Blast against sequences from the two fish species
Zebrafish Danio rerio (Zebrafish Genome Resources at http://
www.ncbi.nlm.nih.gov/projects/genome/guide/zebrafish/) and
Fugu rubripes (Fugu rubripes database v4.0; http://genome.
jgi-psf.org/Takru4/Takru4.home.html) was run separately. The
siRNA target sequences are given in Table 1. The numbers 88,
776 and 932 indicate the target nucleotide starting positions
from the start codon AUG in the mRNA sequence. siRNAs
with 4 mismatches compared to the target sequence were used
as controls of siRNA sequence specificity. Introduction of
mismatches was done according to the following rules:
A ⇔ G and U ⇔ C, 4 mismatches placed with jumps of 5,
5, 2 and 5 nucleotides in the RNA sequence as read from the
5′- to the 3′-end. The resulting sequences are given in Table 1.
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examined by 12% PAGE. A non-silencing control siRNA 5′-
UUCUCCGAACGUGUCACGUdTdT-′3 (sense) and 5′-
ACGUGACACGUUCGGAGAAdTdT-′3 (antisense) labeled
with Fluorescein (Qiagen, Germany, cat. no. 1022079) was
used for measuring transfection efficiency. Both si776 and
si776M were also ordered as synthetic HPP purified siRNAs
(Qiagen, Cat. no 1027020) in order to determine whether
effects seen with the in vitro si776 and si776 were due to the
target-specific sequence.
Transfection of fish cells with siRNAs
Monolayer cultures of EPC cells were grown at 28 °C in
Eagle's minimum essential medium (MEM) (Invitrogen, Cat.
no. 61100-103) supplemented with 10% fetal bovine serum,
100 IU/ml penicillin and 100 μg/ml streptomycin and buffered
with Tris–HCl buffer. Cells were trypsinized, diluted in their
growth medium and 2 × 105 cells seeded into each well of a 24-
well plate and incubated for 24 h before transfection at a cell
confluence of approximately 80%. TransIT-TKO from Mirus
(cat. no. mir2150) was used for transfection of siRNAs into
EPC cells according to manufacturer's protocol. Briefly the
transfection reagent was dissolved in growth medium without
serum, penicillin and streptomycin, vortexed and incubated for
20 min, where after siRNAwas added to give the intended final
concentrations. The siRNA transfection mix was added drop-
wise to the medium above cells after adjusting the medium to
give a final volume of 300 μl per well. Final siRNA
concentrations were 0 nM (mock controls), 20 nM and 80
nM. Triplicate wells of EPC cells with transfection mix were
incubated for 24 h at 28 °C.
Challenge of siRNA-transfected cells with VHSV and
non-specific target control virus
VHSV isolate DK-3592B (Lorenzen et al., 1993) was added
to the cell culture wells 24 h post-siRNA transfection to give a
final concentration of 6 × 102 TCID50/ml in each well. Cell with
virus was incubated at 15 °C until further processing. SVCV
strain 56/80 (Fijan et al., 1971) was used as heterologous non-
specific target control virus. The challenge with the control
virus was done in the same way as for the target virus. IHNV
strain 32/87 (Hattenberger-Baudouy et al., 1989) was also tested
for effectivity as a non-specific target virus. All viruses were
passaged on EPC cells before use.
CPE and viral titer
Cell layers transfected with siRNA and challenged with
virus were observed for cytopathogenic effect (CPE) indicative
of viral replication. Pictures of the cell cultures were taken at
10× magnification using a Leica DMIL light microscope
equipped with a Leica DC300 camera. To determine viral titer
values, medium samples were taken out 72 h post-viral
challenge, diluted in cell growth medium from 10−1 to 10−8 on
a microtiter plate and used for infecting EPC cells in 96-wellplates using 4 replicates per dilution. Titration plates were
incubated at 15 °C for 7 days prior to reading and calculation
of titer values according to the 50% tissue culture infective
dosis (TCID50) method by Reed and Muench (1938). Cells
were reincubated for 24 h, fixed for 5 min using 80% acetone
and stained with 0.5% crystal violet for 5 min to give a whole
cell layer impression of siRNA protection against CPE. Titer
values from cell layers treated with 0, 20 and 80 nM siRNA
were compared by one-way ANOVA and in case of differences
between treatments, values from the 20 and from the 80 nM
treated cells were tested against the mock-treated cells by t test
(P = 0.05).
Expression of Mx in siRNA-transfected EPC cells
Total RNA was purified from EPC cells 24 h post-siRNA
transfection using RNeasy Mini Kit spin-column purification
(Qiagen, Germany, cat. no. 74106) according to the manufac-
turer's protocol for animal cells. For each replicate, material
from two wells was pooled in order to get enough RNA. cDNA
was synthesized from 1 μg of RNA template by using the iScript
cDNA Synthesis Kit from Biorad (USA, cat. no. 170-8891)
following the manufacturer's protocol. Real-time PCR was run
on 25 μl reaction volumes containing a premixed master mix
solution from Stratagene (Brilliant SYBR Green QPCR Master
Mix cat. no. 600548), primers, ROX reference dye, water and 5
μl of the cDNA template diluted ×100. We used previously
published primers designed for a conserved area of theMx1 gene
from crucian carp Carassius auratus (Zhang et al., 2004)
accession number AY303813 to amplify theMx transcripts from
EPC cells. Primer sequences were as follows: CA473-Forward
5′-ACAGAAGGAACTGGAGGCGTA-3′ and CA473-Reverse
5′-CGCAGGTTCCTCCAACAGC-3′. The PCR was run on a
Mx3000p machine from Stratagene, and conditions were set to
an initial denaturation step of 10 min at 95 °C, 40 cycles as
follows: 30 s of denaturation at 95 °C, 1 min of annealing at 55
°C ending with collection of fluorescent data and 30 s of
extension at 72 °C. Finally 1 min at 95 °C, 30 s at 55 °C shifting
to 30 s at 95 °C while fluorescent data for drawing a dissociation
curve were recorded.Mx1 expression was normalized to Carpβ-
actin accession number M24113. Primer sequences were
Forward 5′-GATTCGCTGGAGATGATGCT-3′ and Reverse
5′-GATGGGGTACTTCAGGGTCA-3′. The program for mea-
suring the β-actin level was the same as for Mx1 except that the
40 cycles consisted of 20 s at 94 °C and 1 min at 60 °C with data
collection. The sizes of all PCR products were verified by
inspection of the dissociation curve and by gel electrophoresis of
PCR products.
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